This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Abbvie Inc.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Innovations by Subramanya Hegde: A Pioneer in Glycoengineering
Introduction
Subramanya Hegde is an innovative inventor based in Shrewsbury, MA. He has made significant contributions to the field of biotechnology, focusing on glycoengineered binding proteins. His work addresses critical challenges in drug response and treatment methodologies, showcasing his commitment to advancing medical science.
Latest Patents
Subramanya holds a patent for "Glycoengineered binding protein compositions." This patent describes glycoengineered populations of Fc domain-containing binding proteins that have a reduced anti-drug immune response (ADA). The patent also includes methods of treating diseases using these compositions, as well as techniques and hosts for producing such compositions. His innovative approach may pave the way for more effective therapeutic solutions in various medical applications.
Career Highlights
Subramanya Hegde works at AbbVie Inc., a company renowned for its emphasis on research and development in the biopharmaceutical field. AbbVie focuses on creating advanced therapies for complex diseases, and Hegde's contributions align well with the company's mission. His work is a testament to AbbVie's commitment to innovation and improved patient outcomes.
Collaborations
In his professional journey, Subramanya has collaborated with notable colleagues, including Boris Labkovsky and Tariq Ghayur. These collaborations highlight the importance of teamwork in research and development, enabling the pooling of expertise to enhance innovation in drug design and therapeutic applications.
Conclusion
Subramanya Hegde exemplifies the spirit of innovation and dedication to healthcare improvement through his patented work and collaborations. His contributions to glycoengineering represent a significant advancement in the biopharmaceutical sector, holding promise for the future of drug therapies and patient care. Hegde's journey serves as an inspiration for aspiring inventors in the biotechnology field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile